Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Oncogene ; 36(16): 2228-2242, 2017 04 20.
Article in English | MEDLINE | ID: mdl-27797381

ABSTRACT

Epidermal growth factor (EGF) is important for cancer cell proliferation, angiogenesis and metastasis in many types of cancer. However, the mechanisms involved in EGF-induced head and neck squamous cell carcinoma (HNSCC) metastasis remain largely unknown. In this study, we reveal that angiopoietin-like 4 (ANGPTL4) plays an important role in the regulation of EGF-induced cancer metastasis. We showed that EGF-induced ANGPTL4 expression promoted anoikis resistance and cancer cell migration and invasion in HNSCC. In addition, depletion of ANGPTL4 inhibited EGF-induced cancer cell invasion. Autocrine production of EGF-induced ANGPTL4 regulated the expression of matrix metalloproteinases (MMPs). The induction of MMP-1 gene expression by ANGPTL4-activated integrin ß1 signalling occurred through the AP-1 binding site in the MMP-1 gene promoter. Furthermore, down-regulation of MMP-1 impeded EGF- and recombinant ANGPTL4-enhanced HNSCC cell migration and invasion. Depletion of ANGPTL4 significantly blocked EGF-primed extravasation and metastatic seeding of tumour cells and MMP-1 expression in lungs. However, no effect of ANGPTL4 on tumour growth was observed. These results suggest that EGF-induced expression and autocrine production of ANGPTL4 enhances HNSCC metastasis via the up-regulation of MMP-1 expression. Inhibition of ANGPTL4 expression may be a potential strategy for the treatment of EGFR-mediated HNSCC metastasis.


Subject(s)
Angiopoietins/metabolism , Anoikis , Carcinoma, Squamous Cell/metabolism , Epidermal Growth Factor/physiology , Head and Neck Neoplasms/metabolism , Angiopoietin-Like Protein 4 , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/secondary , Cell Line, Tumor , Genes, jun , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/secondary , Humans , Integrin beta1/metabolism , Matrix Metalloproteinase 1/biosynthesis , Neoplasm Metastasis , Signal Transduction , Squamous Cell Carcinoma of Head and Neck
2.
Transplant Proc ; 48(4): 1007-11, 2016 May.
Article in English | MEDLINE | ID: mdl-27320543

ABSTRACT

BACKGROUND: Living donor liver transplantation may put the donor at risk of physical and psychological impacts. Recovery of physical and psychological function as well as quality of life (QOL) in living liver donors warrants investigation. OBJECTIVES: This study aims to examine the recovery of liver function, emotional status, and QOL in living liver donors through a comparison with the general population and reference values. METHODS: This descriptive, comparative study included 97 living liver donors who underwent surgery from 2008 to 2012 and were divided into 4 groups according to their postoperative period (1 year [n = 31], 2 years [n = 31], 3 years [n = 21], and 4 years above [n = 14]). Data were collected retrospectively in a medical center in northern Taiwan. RESULTS: The mean aspartate aminotransferase level was 20.2-32.1 U/L, the mean alanine aminotransferase level was 14.7-33.5 U/L, and the mean total bilirubin level was 10.8-15.5 µmol/L among the 4 groups. Among donors of the 4 groups, 23.8%-51.6% and 0%-29% were defined as having a mild level of anxiety and depression, respectively. Donors in the 1- and 2-year groups had poorer QOL in the physical function, role physical, vitality, and mental health domains than did the general population of Taiwan (P < .05). CONCLUSIONS: Liver function was at normal levels in all 4 groups. The emotional and psychological function of living liver donors should be monitored and health-related QOL should be promoted during the first and second year after liver donation.


Subject(s)
Emotions , Liver Transplantation/psychology , Liver/physiology , Living Donors/psychology , Quality of Life , Adult , Anxiety/psychology , Depression/psychology , Female , Humans , Male , Mental Health , Recovery of Function/physiology , Retrospective Studies , Taiwan , Time Factors
4.
Genet Mol Res ; 12(2): 1766-76, 2013 May 23.
Article in English | MEDLINE | ID: mdl-23765983

ABSTRACT

The ratio of Bacteroidetes and Firmicutes bacterial groups in the gut can affect the ability to absorb nutrients. We investigated the effect of probiotic Bacillus subtilis supplementation of diets on growth performance, fat deposition, blood lipids, copy numbers, and percentage of Bacteroidetes and Firmicutes in cecal contents, as well as mRNA expression of key lipid metabolism enzymes in the liver and adipose tissue of finishing pigs. Twenty-four Duroc x Meishan crossbreed 8-week-old pigs (10.28 ± 0.59 kg) were randomly allocated to two dietary treatments: maize-soybean meal-based diets with B. subtilis (probiotic group) and without B. subtilis (control group). The probiotic diet led to a significant increase in the average daily gain and feed conversion ratio of pigs weighing 10 to 110 kg. The mean backfat depth was increased while leaf lard weights were decreased by probiotic supplementation. Ingestion of probiotics decreased the serum triglyceride and glucose concentrations, but did not change the levels of total cholesterol and free fatty acids in the serum. The mRNA expressions of fatty acid synthase (FAS) and acetyl-CoA carboxylase α (ACCα) in the liver were down-regulated by the dietary probiotic supplement. Conversely, the gene expressions of FAS and ACCα in the adipose tissue increased. The probiotic diet decreased the copy numbers and percentage of Bacteroidetes, while it increased the percentage of Firmicutes in the cecal contents. We conclude that the addition of B. subtilis improves growth performance and up-regulates lipid metabolism in subcutaneous fat of finishing pigs. We conclude that B. subtilis affects lipid metabolism through regulation of the proportion of Bacteroidetes and Firmicutes in the gut.


Subject(s)
Bacillus subtilis/physiology , Bacteroidetes/growth & development , Diet , Gram-Positive Bacteria/growth & development , Intestines/microbiology , Lipid Metabolism , Swine/microbiology , Adiposity/drug effects , Animals , Bacillus subtilis/drug effects , Bacteroidetes/drug effects , Blood Glucose/metabolism , Gram-Positive Bacteria/drug effects , Intestines/drug effects , Lipid Metabolism/drug effects , Lipids/blood , Meat/standards , Probiotics/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Swine/blood , Swine/genetics , Swine/growth & development
5.
Eur J Clin Microbiol Infect Dis ; 32(6): 807-14, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23334663

ABSTRACT

Only a few studies have investigated the use of PCT in the diagnosis of bone and joint infection, and these studies have had relatively small sample sizes. We performed a systematic review and meta-analysis of the diagnostic performance of serum procalcitonin (PCT) in the identification of osteomyelitis and septic arthritis in patients who present with fever and orthopedic symptoms. EMBASE, MEDLINE, and Cochrane databases and the reference lists of relevant articles were searched, with no language restrictions, through February 2012. All original studies that reported the use of serum PCT alone or in comparison with other biomarkers for diagnosis of osteomyelitis and septic arthritis were included. Seven studies qualified for inclusion. These studies enrolled a total of 583 patients with suspected bone or joint infection, 131 of whom had confirmed osteomyelitis or septic arthritis. Analysis of the PCT data indicated a bivariate pooled sensitivity of 0.67 (95 % CI: 0.37-0.88), specificity of 0.90 (95 % CI: 0.78-0.96), a positive likelihood ratio (LR+) of 6.48 (95 % CI: 2.28-14.6), and a negative likelihood ratio (LR-) of 0.37 (95 % CI: 0.16-0.84). Use of a lower PCT cut-off value (0.2-0.3 ng/mL) improved the LR + to 6.66 and the LR- to 0.15. Analysis of the three studies that also measured serum C-reactive protein (CRP) indicated that CRP had an LR + of 1.39 (95 % CI: 1.17-1.65) and an LR- of 0.40 (95 % CI: 0.12-1.36). Our results indicate that PCT may be more suitable as an aid for rule-in diagnosis rather than for exclusion of septic arthritis or osteomyelitis and that use of a lower cut-off value for serum PCT may improve its diagnostic performance.


Subject(s)
Arthritis, Infectious/blood , Arthritis, Infectious/diagnosis , Calcitonin/blood , Osteomyelitis/blood , Osteomyelitis/diagnosis , Protein Precursors/blood , Calcitonin Gene-Related Peptide , Humans , Odds Ratio , ROC Curve
6.
Br J Surg ; 100(3): 322-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23203918

ABSTRACT

BACKGROUND: The aim was to evaluate the diagnostic value of procalcitonin, C-reactive protein (CRP) and white blood cell count (WBC) in uncomplicated or complicated appendicitis by means of a systematic review and meta-analysis. METHODS: The Embase, MEDLINE and Cochrane databases were searched, along with reference lists of relevant articles, without language restriction, to September 2012. Original studies were selected that reported the performance of procalcitonin alone or in combination with CRP or WBC in diagnosing appendicitis. Test performance characteristics were summarized using hierarchical summary receiver operating characteristic (ROC) curves and bivariable random-effects models. RESULTS: Seven qualifying studies (1011 suspected cases, 636 confirmed) from seven countries were identified. Bivariable pooled sensitivity and specificity were 33 (95 per cent confidence interval (c.i.) 21 to 47) and 89 (78 to 95) per cent respectively for procalcitonin, 57 (39 to 73) and 87 (58 to 97) per cent for CRP, and 62 (47 to 74) and 75 (55 to 89) per cent for WBC. ROC curve analysis showed that CRP had the highest accuracy (area under ROC curve 0·75, 95 per cent c.i. 0·71 to 0·78), followed by WBC (0·72, 0·68 to 0·76) and procalcitonin (0·65, 0·61 to 0·69). Procalcitonin was found to be more accurate in diagnosing complicated appendicitis, with a pooled sensitivity of 62 (33 to 84) per cent and specificity of 94 (90 to 96) per cent. CONCLUSION: Procalcitonin has little value in diagnosing acute appendicitis, with lower diagnostic accuracy than CRP and WBC. However, procalcitonin has greater diagnostic value in identifying complicated appendicitis. Given the imperfect accuracy of these three variables, new markers for improving medical decision-making in patients with suspected appendicitis are highly desirable.


Subject(s)
Appendicitis/diagnosis , C-Reactive Protein/analysis , Calcitonin/blood , Leukocyte Count/methods , Protein Precursors/blood , Acute Disease , Adult , Biomarkers/analysis , Biomarkers/blood , Calcitonin Gene-Related Peptide , Child , Humans , ROC Curve , Sensitivity and Specificity
7.
J Int Med Res ; 40(2): 556-64, 2012.
Article in English | MEDLINE | ID: mdl-22613416

ABSTRACT

OBJECTIVE: T helper 17 (Th17) cells play important roles in adaptive immunity and are involved in several inflammatory and autoimmune diseases, but little is known about their role in tumour immunity. The current study investigated the involvement of Th17 cells in multiple myeloma. METHODS: Flow cytometry was used to investigate the frequencies of Th17 cells in peripheral blood mononuclear cells from 30 patients with multiple myeloma and from 14 healthy control subjects. The concentrations of Th17-associated cytokines (interleukin [IL]-6, IL-17, IL-1ß and IL-23) were measured by enzyme-linked immunosorbent assay. RESULTS: There was a significantly increased proportion of Th17 cells, and increased plasma concentrations of Th17-associated cytokines, in patients with multiple myeloma compared with healthy controls. There was a significant relationship between the proportion of Th17 cells and clinical tumour stage, serum lactate dehydrogenase concentration and serum creatinine concentration. CONCLUSIONS: Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate a better outcome for tumour immunotherapy.


Subject(s)
Multiple Myeloma/immunology , Th17 Cells/immunology , Aged , Antineoplastic Agents/therapeutic use , CD4 Lymphocyte Count , Creatinine/blood , Female , Humans , Interleukin-1/blood , Interleukin-17/blood , Interleukin-1beta/blood , Interleukin-6/blood , L-Lactate Dehydrogenase/blood , Male , Multiple Myeloma/drug therapy , Multiple Myeloma/pathology
8.
J Appl Microbiol ; 108(4): 1398-407, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19796120

ABSTRACT

AIMS: To identify proteins regulating antimicrobial peptide (AMP) resistance in Vibrio parahaemolyticus using membrane subproteome analysis. METHODS AND RESULTS: Three synthetic AMPs (Q4, Q6 and H1) and a natural one from fish (pleurocidin) were used for selection of AMP-resistant strains. Differential expression patterns of the outer and inner membrane proteins (OMPs and IMPs) among wild-type and the resistant strains were obtained using two-dimensional gel electrophoresis. Two OMPs (TolC and flagellin) and five IMPs [transcription termination factor (NusA), long-chain fatty acid transport protein (FadL), elongation factor Tu (EF-Tu), ATP synthase F1, alpha subunit (F1-ATPa) and dihydrolipoamide dehydrogenase (DLD)] were identified using LC-ESI-Q-TOF MS/MS and Mascot program. Real-time quantitative polymerase chain reaction was also performed to determine the mRNA expression level of the target genes. All seven membrane proteins except FadL were upregulated in the AMP-resistant clones, both in the translational and transcriptional levels. CONCLUSIONS: Our results suggested that V. parahaemolyticus may obtain their resistance against AMPs through upregulation of the multidrug efflux transporter, effective repair of damaged membranes and prevention of cellular penetration of AMPs. SIGNIFICANCE AND IMPACT OF THE STUDY: To the best of our knowledge, this is the first report describing bacterial AMP resistance mechanism using proteomic methodologies. Elucidating the mechanism could help in the development of more sustainable antimicrobial agents.


Subject(s)
Anti-Infective Agents/pharmacology , Membrane Proteins/metabolism , Proteomics , Vibrio parahaemolyticus/drug effects , Vibrio parahaemolyticus/metabolism , Drug Resistance, Bacterial/genetics , Membrane Proteins/genetics , Membrane Proteins/pharmacology , Microbial Sensitivity Tests , Peptides/genetics , Peptides/metabolism , Peptides/pharmacology , Vibrio parahaemolyticus/genetics
10.
Mol Cell Biol ; 20(19): 7401-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10982856

ABSTRACT

C methylation at genomic CpG dinucleotides has been implicated in the regulation of a number of genetic activities during vertebrate cell differentiation and embryo development. The methylated CpG could induce chromatin condensation through the recruitment of histone deacetylase (HDAC)-containing complexes by methyl-CpG-binding proteins. These proteins consist of the methylated-DNA binding domain (MBD). Unexpectedly, however, several studies have identified MBD-containing proteins encoded by genes of Drosophila melanogaster, an invertebrate species supposed to be void of detectable m(5)CpG. We now report the genomic structure of a Drosophila gene, dMBD2/3, that codes for two MBD-containing, alternatively spliced, and developmentally regulated isoforms of proteins, dMBD2/3 and dMBD2/3Delta. Interestingly, in vitro binding experiments showed that as was the case for vertebrate MBD proteins, dMBD2/3Delta could preferentially recognize m(5)CpG-containing DNA through its MBD. Furthermore, dMBD2/3Delta as well as one of its orthologs in mouse, MBD2b, could function in human cells as a transcriptional corepressor or repressor. The activities of HDACs appeared to be dispensable for transcriptional repression by dMBD2/3Delta. Finally, dMBD2/3Delta also could repress transcription effectively in transfected Drosophila cells. The surprisingly similar structures and characteristics of the MBD proteins as well as DNA cytosine (C-5) methyltransferase-related proteins in Drosophila and vertebrates suggest interesting scenarios for their roles in eukaryotic cellular functions.


Subject(s)
CpG Islands , DNA Methylation , DNA-Binding Proteins/physiology , Gene Expression Regulation , Genes, Insect , Insect Proteins/physiology , Repressor Proteins/physiology , Transcription, Genetic , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Chromatin/metabolism , Chromatin/ultrastructure , DNA/genetics , DNA/metabolism , DNA, Complementary/genetics , DNA-Binding Proteins/genetics , Evolution, Molecular , Histone Deacetylases/physiology , Humans , Mice , Molecular Sequence Data , Recombinant Fusion Proteins/physiology , Species Specificity
11.
Proc Natl Acad Sci U S A ; 96(21): 11940-5, 1999 Oct 12.
Article in English | MEDLINE | ID: mdl-10518555

ABSTRACT

DNA methylation at CpG residues is closely associated with a number of biological processes during vertebrate development. Unlike the vertebrates, however, several invertebrate species, including the Drosophila, do not have apparent DNA methylation in their genomes. Nor have there been reports on a DNA (5-cytosine) methyltransferase (CpG MTase) found in these invertebrates. We now present evidence for two CpG MTase-like proteins expressed in Drosophila cells. One of these, DmMTR1, is a protein containing peptide epitopes immunologically related to the conserved motifs I and IV in the catalytic domain of the mammalian dnmt1. DmMTR1 has an apparent molecular mass of 220 kDa and, similar to mammalian dnmt1, it also interacts in vivo with the proliferating cell nuclear antigen. During interphase of the syncytial Drosophila embryos, the DmMTR1 molecules are located outside the nuclei, as is dnmt1 in the mouse blastocyst. However, DmMTR1 appears to be rapidly transported into, and then out of the nuclei again, as the embryos undergo mitotic waves. Immunofluorescent data indicate that DmMTR1 molecules "paint" the whole set of condensed Drosophila chromosomes throughout the mitotic phase, suggesting they may play an essential function in the cell-cycle regulated condensation of the Drosophila chromosomes. Through search in the genomic database, we also have identified a Drosophila polypeptide, DmMT2, that exhibits high sequence homology to the mammalian dnmt2 and the yeast CpG MTase homolog pmt1. The expression of DmMT2 appears to be developmentally regulated. We discuss the evolutionary and functional implications of the discovery of these two Drosophila proteins related to mammalian CpG MTases.


Subject(s)
DNA (Cytosine-5-)-Methyltransferases/genetics , Drosophila/genetics , Amino Acid Sequence , Animals , Blotting, Northern , Blotting, Western , Chromatin/genetics , CpG Islands , Drosophila/enzymology , Glutathione Transferase/metabolism , Humans , Mice , Mitosis , Models, Genetic , Molecular Sequence Data , Precipitin Tests , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid
12.
J Biol Chem ; 272(39): 24105-8, 1997 Sep 26.
Article in English | MEDLINE | ID: mdl-9305852

ABSTRACT

NF-E2 is an erythroid-specific transcription factor required for expression of several erythroid-specific genes. By Far-Western blotting and yeast two-hybrid assay, we demonstrate that p45, the large subunit of NF-E2, is capable of binding to a specific set of WW domain-containing proteins, including the ubiquitin ligase hRPF1. This binding is mediated through the interaction between the WW domains and a PY motif located within the amino-terminal region of p45. Interestingly, the carboxyl-terminal domain of mammalian RNA polymerase II binds a similar set of WW domains to which p45 interacts with. We discuss the data in terms of possible new pathways through which the processes of transcriptional regulation by NF-E2 could be regulated in erythroid and megakaryote cells.


Subject(s)
Bone Marrow/metabolism , DNA-Binding Proteins/metabolism , RNA Polymerase II/metabolism , Transcription Factors/metabolism , Amino Acid Sequence , Erythroid-Specific DNA-Binding Factors , Molecular Sequence Data , NF-E2 Transcription Factor , NF-E2 Transcription Factor, p45 Subunit , Protein Binding , RNA Polymerase II/chemistry , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid
14.
Nucleic Acids Res ; 3(4): 931-51, 1976 Apr.
Article in English | MEDLINE | ID: mdl-818625

ABSTRACT

The five satellite DNAs of Drosophila melanogaster have been isolated by the combined use of different equilibrium density gradients and hydrolyzed by seven different restriction enzymes; Hae III, Hind II + Hind III, Hinf, Hpa II, EcoR I and EcoR II. The 1.705 satellite is not hydrolyzed by any of the enzymes tested. Hae III is the only restriction enzyme that cuts the 1.672 and 1.686 satellites. The cleavage products from either of these reactions has a heterogeneous size distribution. Part of the 1.688 satellite is cut by Hae III and by Hinf into three discrete fragments with M.W. that are multiples of 2.3 X 10(5) daltons (approximately 350 base pairs). In addition, two minor bands are detected in the 1.688-Hinf products. The mole ratios of the trimer, dimer and monomer are: 1:6.30 : 63.6 for 1.688-Hae III and 1 : 22.0 : 403 for 1.688-Hinf. Circular mitochondrial DNA (rho = 1.680) is cut into discrete fragments by all of the enzymes tested and molecular weights of these fragments have been determined.


Subject(s)
DNA Restriction Enzymes/metabolism , DNA, Satellite , DNA , Drosophila melanogaster/metabolism , Endonucleases/metabolism , Animals , Base Sequence , DNA/isolation & purification , DNA, Satellite/isolation & purification , Electrophoresis , Electrophoresis, Polyacrylamide Gel , Escherichia coli/enzymology , Haemophilus influenzae/enzymology , Mathematics , Molecular Weight , Sepharose
SELECTION OF CITATIONS
SEARCH DETAIL
...